New York Times
Novo Nordisk Adds Diabetes Research to Seattle Immunology Team
Xconomy
Novo Nordisk, the world's largest maker of diabetes treatments, is increasing its bet on Seattle's biomedical research community. Denmark-based Novo said today it is establishing a new center with 20 scientists in Seattle who will conduct research into
Novo Nordisk Establishes Type 1 Diabetes R&D Center in SeattlePR Newswire (press release)
La Jolla Institute Scientist Takes Quest to Conquer Type 1 Diabetes to the Newswise (press release)
Corporate Rule Is Not InevitableNew York Times (blog)
3BL Media (press release)
all 17 news articles »

diabetes – Google News

Speak Your Mind

*